title: [Collaborative study on regulatory science for facilitating clinical development of gene therapy products for genetic diseases].
abstract: Gene therapy products are expected as innovative medicinal products for intractable diseases such as life-threatening genetic diseases and cancer. Recently, clinical developments by pharmaceutical companies are accelerated in Europe and the United States, and the first gene therapy product in advanced countries was approved for marketing authorization by the European Commission in 2012. On the other hand, more than 40 clinical studies for gene therapy have been completed or ongoing in Japan, most of them are conducted as clinical researches by academic institutes, and few clinical trials have been conducted for approval of gene therapy products. In order to promote the development of gene therapy products, revision of the current guideline and/or preparation of concept paper to address the evaluation of the quality and safety of gene therapy products are necessary and desired to clearly show what data should be submitted before First-in-Human clinical trials of novel gene therapy products. We started collaborative study with academia and regulatory agency to promote regulatory science toward clinical development of gene therapy products for genetic diseases based on lentivirus and adeno-associated virus vectors; National Center for Child Health and Development (NCCHD), Nippon Medical School and PMDA have been joined in the task force. At first, we are preparing pre-draft of the revision of the current gene therapy guidelines in this project.
authors.forename: Eriko
authors.initials: E
authors.lastname: Uchida
authors.forename: Yuka
authors.initials: Y
authors.lastname: Igarashi
authors.forename: Yoji
authors.initials: Y
authors.lastname: Sato
mesh_terms: D003299:Cooperative Behavior; D000229:Dependovirus; D055808:Drug Discovery; D030342:Genetic Diseases, Inborn / Q000628:therapy*; D015316:Genetic Therapy; D005822:Genetic Vectors; D006077:Government Agencies; D006298:Health Services Administration; D006801:Humans; D007564:Japan; D016086:Lentivirus; D017410:Practice Guidelines as Topic; D012577:Schools, Medical / Q000458:organization & administration*; D057170:Translational Research, Biomedical